Endometriosis, an enigmatic and chronic disorder, is considered a debilitating condition
despite being benign. Globally, this gynecologic disorder affects up to 10% of females of …

Since the COVID-19 pandemic, some of the routine methods for clinical diagnosis of
infectious diseases have become closer to the general population and terms like …

Background The discovery of a saliva-based micro–ribonucleic acid (miRNA) signature for
endometriosis in 2022 opened up new perspectives for early and noninvasive diagnosis of …

STUDY QUESTION Can cartilage oligomeric matrix protein (COMP) and transforming
growth factor-β-induced protein ig-h3 (TGFBI) alone or in combination with cancer antigen …

Endometriosis, a benign gynecologic and chronic inflammatory disease, is defined by the
presence of endometrial tissue outside the uterus characterized mainly by pelvic pain and …

Patients with a history of endometriosis have an increased risk of developing various
autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, systemic lupus …

Endometriosis is a common estrogen‐dependent disorder wherein uterine lining tissue
(endometrium) is found mainly in the pelvis where it causes inflammation, chronic pelvic …

Endometriosis, a systemic ailment, profoundly affects various aspects of life, often eluding
detection for over a decade. This leads to enduring issues such as chronic pain, infertility …

In recent years, magnetic nanoparticles (MNPs) have been widely used in many fields due
to their advantageous properties, such as biocompatibility, easy modifiability, and high …

Objective To evaluate blood‐based biomarkers to detect endometriosis and/or adenomyosis
across nine European centers (June 2014–April 2018). Methods This prospective, non …